LRMR EPS Estimates
Larimar Therapeutics, Inc.
$1.98
-$0.11(-5.50%)
27
Overall
60
Value
9
Tech
13
Quality
Market Cap
$217.12M
Volume
1.73M
52W Range
$2.61 - $6.42
Target Price
$14.40
LRMR EPS estimates: the consensus estimate for Larimar Therapeutics, Inc.'s current fiscal year is -$1.37 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
LRMR EPS Estimates
- EPS estimate, current quarter
- $-0.35
- EPS estimate, next quarter
- $-0.37
- EPS estimate, current year
- $-1.37
- EPS estimate, next year
- $-1.32
- EPS growth, 3-year
- -18.33%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.27 |
| 2024 | $-1.32 |
| 2023 | $-0.84 |
| 2022 | $-1.37 |
| 2021 | $-2.95 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LRMR | $1.98 | -5.5% | 1.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Larimar Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW